Thomas McLain
Now let’s move on to Vermillion, a molecular diagnostics company focused on gynaecologic cancers and women's health, who has announced a couple of big appointments.
First off, ex CEO and CFO of Claro Scientific Thomas McLain has been appointed as President and CEO.
McLain has over 20 years of experience in executive management and corporate governance and has worked at companies including Nabi Biopharmaceuticals and Bausch & Lomb.
“We expect to benefit from Tom's seasoned skills, abilities and insights as we pursue strategies that expand our product pipeline and advance the development and commercial adoption of our diagnostic tests,” said James Burns who, at the time, was Chairman of the Board…